Business Wire: latest releases

News releases provided by Business Wire Business Wire.

Exscientia Business Update for Second Quarter and First Half 2022

Retrieved on: 
Wednesday, August 17, 2022 - 9:01pm

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220817005681/en/
    Recent developments in the Companys pipeline, collaborations, and operations, as well as financial results for the second quarter and first half 2022, are summarised below.
  • In addition, Exscientia will host a conference call Thursday, August 18 at 1:30 p.m. BST / 8:30 a.m.
  • In the first half of 2022, we delivered on major new and existing collaborations, advanced our pipeline programmes, and marked the 10-year anniversary of Exscientias founding.
  • A replay will be available for 90 days under "Events and Presentations in the Investors and Media section of the Exscientia website .

The Princeton Review Again Names Hillsdale College One of Best in Nation

Retrieved on: 
Wednesday, August 17, 2022 - 8:16pm

In its annual rankings, The Princeton Review has again named Hillsdale College among one of the best in the country.

Key Points: 
  • In its annual rankings, The Princeton Review has again named Hillsdale College among one of the best in the country.
  • This year, The Princeton Review collected data from 160,000 college students from 388 colleges across America.
  • The sense of partnership between students, faculty members, and staff members is what makes Hillsdale College so successful, said Hillsdale College Provost Christopher VanOrman.
  • Some of Hillsdale Colleges other highest rankings include:
    Click here to view Hillsdale Colleges profile by The Princeton Review.

2 Twelve Solutions Awarded US Navy Production Contract to Operationalize Modern Enterprise Capabilities Into a Global Secure Enterprise Network

Retrieved on: 
Wednesday, August 17, 2022 - 8:39pm

To transform, digitize, and govern its enterprise networks, the U.S. Navy has chosen a comprehensive technology solution from 2 Twelve Solutions, Reston, Virginia.

Key Points: 
  • To transform, digitize, and govern its enterprise networks, the U.S. Navy has chosen a comprehensive technology solution from 2 Twelve Solutions, Reston, Virginia.
  • On 3 August 2022, the Navy awarded 2 Twelve Solutions a $93.5 million Other Transaction Agreement (OTA) to productionize the firms highly successful prototype for operationalizing modern enterprise capabilities.
  • At the heart of the solution is 2 Twelve Solutions' advanced application programming interface (API), multi-cloud platform and Orchestrated Repository for the Enterprise (ORE), leveraging 2 Twelve Solutions' world-class, highly secure datacenter infrastructure.
  • We are thrilled and honored to continue our partnership with the Navy through this contract award, said Lloyd Osafo, Founder and CEO of 2 Twelve Solutions.

Perimeter Medical Imaging AI Announces Conference Call and Webcast to Discuss Second Quarter 2022 Financial Results and Provide Corporate Update

Retrieved on: 
Wednesday, August 17, 2022 - 9:01pm

About Perimeter Medical Imaging AI, Inc.

Key Points: 
  • About Perimeter Medical Imaging AI, Inc.
    Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need.
  • Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level.
  • The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation, artificial intelligence technology that is currently under clinical development.
  • Without limitation, information regarding the potential benefits of Perimeter S-Series OCT, Perimeter B-Series OCT, and Perimeter ImgAssist are forward-looking information.

Harpak-ULMA Selected to Support Federal Pipette Tip Production Contract

Retrieved on: 
Wednesday, August 17, 2022 - 8:36pm

Harpak-ULMA, the industry leader in smart, connected packaging solutions, has been selected by a major medical device producer to provide automated flow wrap packaging lines for pipette tip production.

Key Points: 
  • Harpak-ULMA, the industry leader in smart, connected packaging solutions, has been selected by a major medical device producer to provide automated flow wrap packaging lines for pipette tip production.
  • The move will ensure reliable, US-based production of a vital tool utilized to dispense precise amounts of liquid in disease research and diagnostic labs.
  • View the full release here: https://www.businesswire.com/news/home/20220817005577/en/
    Harpak-ULMA end-to-end packaging solutions incorporate product loading, primary, secondary, and tertiary packaging capabilities.
  • The companys solutions will meet or exceed the high levels of scalability, medical device packaging quality, and overall throughput demanded at extreme production levels.

Terran Orbital’s Roger Teague to Present at 2022 Space Warfighting Integration Forum

Retrieved on: 
Thursday, August 18, 2022 - 2:50am

Terran Orbital Corporation (NYSE: LLAP ), a global leader in satellite solutions, primarily serving the United States and Allied aerospace and defense industries, today announced its participation in the 2022 Space Warfighting Integration Forum.

Key Points: 
  • Terran Orbital Corporation (NYSE: LLAP ), a global leader in satellite solutions, primarily serving the United States and Allied aerospace and defense industries, today announced its participation in the 2022 Space Warfighting Integration Forum.
  • Sponsored by the National Defense Industrial Association (NDIA), the forum will take place in Colorado Springs and will feature leaders from across the aerospace and defense industry.
  • View the full release here: https://www.businesswire.com/news/home/20220817005261/en/
    Terran Orbitals Roger Teague to Present at 2022 Space Warfighting Integration Forum (Credit: Terran Orbital Corporation)
    Roger Teague, President of Defense and Intelligence Systems at Terran Orbital, will present during the Going Fast: Opportunities and Challenges for Delivering Capabilities to the Warfighter panel on August 19.
  • Terran Orbital is a leading manufacturer of satellites primarily serving the United States and Allied aerospace and defense industries.

Keller Williams to Kick Off Mega Camp on August 23

Retrieved on: 
Wednesday, August 17, 2022 - 8:00pm

Keller Williams (KW), the worlds largest real estate franchise by agent count, has once again opened its Austin, Texas-based Mega Camp, a leading annual real estate training conference, to agents across the real estate industry.

Key Points: 
  • Keller Williams (KW), the worlds largest real estate franchise by agent count, has once again opened its Austin, Texas-based Mega Camp, a leading annual real estate training conference, to agents across the real estate industry.
  • And, we are inviting agents across our industry to Mega Camp to learn how to build a business worth owning and to enjoy a life worth living.
  • On August 23, Keller, Papasan and Ruben Gonzalez, the chief economist of Keller Williams, will open the event with a deep dive into the mechanics of the housing market, the economy, and the industry.
  • Austin, Texas-based Keller Williams (KW), the worlds largest real estate franchise by agent count, has more than 1,100 offices and 200,000 associates.

bluebird bio Announces U.S. Commercial Infrastructure to Enable Patient Access to ZYNTEGLO®, the First and Only FDA-Approved Gene Therapy for People with Beta-Thalassemia Who Require Regular Red Blood Cell Transfusions

Retrieved on: 
Wednesday, August 17, 2022 - 7:32pm

This outcomes measure is recognized by payers and providers as clinically meaningful and straightforward to track through claims data.

Key Points: 
  • This outcomes measure is recognized by payers and providers as clinically meaningful and straightforward to track through claims data.
  • bluebird bio has the longest and most robust clinical program in transfusion-dependent betathalassemia (TDT) in the field of gene therapy.
  • ZYNTEGLO is a first-in-class, one-time ex-vivo LVV gene therapy approved for the treatment of beta-thalassemia in adult and pediatric patients who require regular red blood cell transfusions.
  • ZYNTEGLO is indicated for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell (RBC) transfusions.

The Law Offices of Frank R. Cruz Announces Investigation of Sema4 Holdings Corp. (SMFR, SMFRW) on Behalf of Investors

Retrieved on: 
Wednesday, August 17, 2022 - 7:28pm

The Law Offices of Frank R. Cruz announces an investigation of Sema4 Holdings Corp. (Sema4 or the Company) (NASDAQ: SMFR , SMFRW ) on behalf of investors concerning the Companys possible violations of federal securities laws.

Key Points: 
  • The Law Offices of Frank R. Cruz announces an investigation of Sema4 Holdings Corp. (Sema4 or the Company) (NASDAQ: SMFR , SMFRW ) on behalf of investors concerning the Companys possible violations of federal securities laws.
  • On July 22, 2021, CM Life Sciences, Inc., a special purpose acquisition company, completed its business combination with Mount Sinai Genomics, Inc., and the combined public entity was renamed Sema4.
  • Less than a year later, on June 14, 2022, Sema4 announced that its Chief Financial Officer had departed.
  • On this news, Sema4s stock fell $0.80, or 33.3%, to close at $1.60 per share on August 16, 2022, thereby injuring investors.

bluebird bio Announces FDA Approval of ZYNTEGLO®, the First Gene Therapy for People with Beta-Thalassemia Who Require Regular Red Blood Cell Transfusions

Retrieved on: 
Wednesday, August 17, 2022 - 7:03pm

The Cooleys Anemia Foundation applauds the FDAs approval of ZYNTEGLO for people with betathalassemia who require regular red blood cell transfusions.

Key Points: 
  • The Cooleys Anemia Foundation applauds the FDAs approval of ZYNTEGLO for people with betathalassemia who require regular red blood cell transfusions.
  • bluebird bio has the longest and most robust clinical program in transfusion-dependent betathalassemia (TDT) in the field of gene therapy.
  • ZYNTEGLO is a first-in-class, one-time ex-vivo LVV gene therapy approved for the treatment of beta-thalassemia in adult and pediatric patients who require regular red blood cell (RBC) transfusions.
  • ZYNTEGLO is indicated for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell (RBC) transfusions.